Key facts
- This page summarizes Kevin E. Lofton's Form 4 filing for Medtronic plc (MDT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 May 2022, 18:17.
Kevin E. Lofton - 02 May 2022 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- Director
- Issuer ticker
- MDT
- Reported as of
- 02 May 2022
- Net transaction value
- -$16,601
- SEC form
- 4
- Accepted by SEC
- 04 May 2022, 18:17:00 UTC
- Prior SEC filing
- 29 Apr 2022
- Next SEC filing
- 03 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas L. Osteraas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kevin E. Lofton filed Form 4 for Medtronic plc (MDT) on 04 May 2022.
Change
- Previous filing in this sequence was filed on 29 Apr 2022.
- Current net transaction value: -$16,601.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +1,697
- Change %
- +203%
- Price
- $0.000000
- Shares after
- 2,535
- Date
- 02 May 2022
- Ownership
- Direct
MDT
transaction
Ordinary Shares
Tax liability
- Transaction value
- $16,601
- Shares
- -161
- Change %
- -6.4%
- Price
- $103.11
- Shares after
- 2,374
- Date
- 03 May 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This balance increased by 18 shares due to exempt transactions such as dividend reinvestment.